ZNF746 (zinc finger protein 746) is a transcription repressor that binds to specific DNA consensus sequences and regulates gene expression with significant implications for neurodegeneration and cancer progression. The protein functions primarily as a transcriptional repressor, specifically binding to 5'-TATTTT[T/G]-3' consensus sequences to suppress PGC-1α (PPARGC1A) transcription 1. In Parkinson's disease, ZNF746 accumulates when parkin activity is lost, as parkin normally targets ZNF746 for proteasomal degradation through ubiquitination 12. This accumulation contributes to mitochondrial dysfunction and dopamine neuron death through reactive oxygen species generation and NLRP3 inflammasome activation 1. Beyond neurodegeneration, ZNF746 demonstrates oncogenic properties in multiple cancer types. In colorectal cancer, it enhances c-Myc stability through direct protein binding and modulation of GSK3β and FBW7-mediated degradation pathways, promoting tumor progression 34. Similarly, in breast cancer, ZNF746 promotes M2 macrophage polarization via the Jagged1/Notch pathway, facilitating tumor progression and metastasis 5. The protein also suppresses epithelial-to-mesenchymal transition markers in lung cancer cells 6. These findings establish ZNF746 as a critical regulator linking transcriptional control to both neurodegeneration and cancer pathogenesis.